UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2023

 

Commission File Number 001-37381

 

MEDIGUS LTD.
(Translation of registrant’s name into English)

 

10 HaNechoshet Street Tel-Aviv, 6971072, Israel 

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F ☐

 

 

 

 

 

 

EXPLANATORY NOTE

 

This Report of Foreign Issuer on Form 6-K (“Form 6-K”) is being furnished by Medigus Ltd. (the “Company”) to the Securities and Exchange Commission (the “SEC”) for the sole purpose of furnishing: (i) unaudited, condensed consolidated financial statements of the Company as of and for six months ended June 30, 2023; (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations, which discusses and analyzes the Company’s financial condition and results of operation as of and for the six months ended June 30, 2023 and (iii) a press release titled: “Medigus Announces $53.3 million in Revenues for the First Six Months of 2023”.

 

This report on Form 6-K, other than Exhibit 99.3, is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-271984) and Form S-8 (File No. 333-274190, No. 333-258624, No. 333-206803, No. 333-221019 and No. 333-229429).

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

  MEDIGUS LTD.
     
Date: September 28, 2023 By: /s/ Tali Dinar
    Tali Dinar
    Chief Financial Officer

 

2

 

 

EXHIBIT INDEX

 

Exhibit   Description
     
99.1   Interim Condensed Consolidated Financial Statements (Unaudited) as of June 30, 2023.
     
99.2   Operating and Financial Review as of June 30, 2023, and for the Six Months then Ended.
     
99.3   Press release dated September 28, 2023
     
101.INS   Inline XBRL Instance Document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

3